| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |